NCT00896896: Immunoreactivity to Cetuximab in Cancer Patients |
|
|
| Completed | N/A | 538 | US | immunologic technique, None indicated, laboratory biomarker analysis | Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) | Colorectal Cancer, Head and Neck Cancer | 10/08 | 10/08 | | |
